Novo Nordisk NOVO.B-0.75%decrease; red down pointing triangle said the Food and Drug Administration accepted its submission of a new drug application for a Wegovy pill to treat obesity amid a ...

Novo Nordisk NOVO.B3.98%increase; green up pointing triangle shares fell Tuesday after Eli Lilly LLY-1.07%decrease; red down pointing triangle announced results of a new pill that could rival the ...

Novo Nordisk's sales have been growing fast thanks to GLP-1 medicines like Ozempic for diabetes and Wegovy for weight management. In 2024, revenue increased by 25% year over year to 290 billion ...

Novo Nordisk is going to expand its operations in Johnston County with a $4 billion investment. State Health Plan ends coverage of weight-loss drugs as costs surge ...

Novo Nordisk said on Wednesday it would begin selling its weight-loss drug Wegovy at a discounted price of $499 per month to patients paying cash, as it grapples with shifts to the competitive ...

Novo Nordisk, the company behind Ozempic and Wegovy, is now Europe's largest company as global demand for its drugs have soared. But the Danish pharmaceutical company's origins were motivated by ...

Novo Nordisk will invest $4.1 billion to develop a new manufacturing facility in the U.S., which will be used to boost production for the company’s weight loss and diabetes drugs Wegovy and ...

You can reach Elaine on Signal at elaineywchen.70. Novo Nordisk on Tuesday reported that its new obesity pill that targets the amylin hormone led to substantial weight loss in an early study ...

The entrance to one of Novo Nordisk ... Research Triangle Park with laying a groundwork for the area to attract global businesses decades later. Construction crews work on Novo Nordisk’s ...